
Treatment.Com International Inc. (TRUE.CN) Stock Overview
Explore Treatment.Com International Inc.’s financial performance, market position, analyst ratings, and future outlook.
Treatment.Com International Inc. (TRUE.CN)
Key Financials
Key Financials
Market Cap
38.5M
P/E Ratio
-6.31
EPS (TTM)
$-0.19
ROE
-0.93%
TRUE.CN Stock Analysis & Investment Overview (CNQ)
Our AI-powered analysis of Treatment.Com International Inc. (CNQ: TRUE.CN) gives investors deep insight into how the stock performs on the CNQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Treatment.Com International Inc.'s CNQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of TRUE.CN on the CNQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the CNQ listing.
Key metrics behind Treatment.Com International Inc.'s CNQ-traded stock include a P/E ratio of -6.31 and a market capitalization of 38.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of TRUE.CN on the CNQ.